GlucoTrack Investor Relations Material
Latest events
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies
Latest reports from GlucoTrack Inc
Access all reports
GlucoTrack, Inc. is a medical device company focused on developing and commercializing innovative technologies designed for people with diabetes. The company’s flagship product, also named GlucoTrack, is a non-invasive glucose monitoring device that allows users to obtain blood glucose readings without the need for fingersticks or other invasive procedures. Additionally, GlucoTrack is working on a long-term implantable continuous blood glucose monitor (CBGM) aimed at providing accurate, continuous glucose monitoring for extended periods, addressing challenges such as calibration and comfort found in traditional CGM systems. GlucoTrack, Inc. is headquartered in Rutherford, New Jersey, and its shares are listed on the NASDAQ.
Latest articles
)
Intuitive Surgical: Enhancing Surgery with Robotic Precision
Intuitive Surgical has revolutionized surgery with robotics, building its dominant position through decades of innovation, validation, and expansion.
2 May 2025
)
Moncler: From the Mountains to the Runway
The story of Moncler, all the way from its beginnings in the Alps to its journey to some of the most prestigious runways in the world.
16 Apr 2025
)
eToro: Innovation, Growth, and IPO Plans
eToro was founded in 2007 and has grown into a global trading platform with over 40 million users and an extensive offering across several asset classes.
10 Apr 2025
Ticker symbol
GCTK
Country
🇺🇸 United States